Stryker Acquires Cerus Endovascular

Stryker Acquires NICO Corporation

September 20, 2024

Medical Devices

Stryker has completed the acquisition of NICO Corporation, a privately held developer of minimally invasive neurosurgical systems including BrainPath and Myriad. The purchase expands Stryker's neurotechnology portfolio and strengthens its capabilities in tumor resection and treatment of intracerebral hemorrhage (stroke) worldwide.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

VB Spine Acquires Stryker's Cestas Manufacturing Facility

January 6, 2026

Medical Devices

VB Spine LLC completed the acquisition of Stryker’s spinal implant manufacturing facility in Cestas, France, transferring site employees and operations to VB Spine. The deal expands VB Spine’s global manufacturing footprint and is financed in part by equity investors Viscogliosi Brothers entities with support from Barings.

Stryker Corporation Acquires Vocera Communications

February 23, 2022

Healthcare Services

Stryker Corporation completed the acquisition of Vocera Communications, Inc., a provider of clinical communication and workflow solutions, with the effective date of the transaction on February 23, 2022. The deal integrates Vocera's digital care-coordination platform and wearable communication devices into Stryker’s medical technology portfolio; the announcement also triggered change-of-control rights for holders of Vocera's convertible notes.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

ICU Medical Acquires Pursuit Vascular

November 4, 2019

Medical Devices

ICU Medical, Inc. agreed to acquire Pursuit Vascular, Inc. for $75 million plus a potential earnout, bringing the ClearGuard HD antimicrobial catheter cap into ICU Medical’s consumables portfolio. The acquisition expands ICU Medical’s infection-prevention product offerings and distribution channels (domestic and international); Pursuit Vascular’s 2019 revenue was an estimated $10–12 million.